June 29 (Reuters) – Ipsen will buy U.S.-based Kartos Therapeutics for $450 million to expand its oncology pipeline with a late-stage blood cancer treatment, the French biotech company said on Monday.
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Cubarsi champions defenders' cause but keeps his feet on the ground at home
VIDEO SHOWS: INTERVIEW WITH SPAIN'S CENTRE-BACK PAU CUBARSI / ARCHIVE OF CUBARSI TRAINING WITH SPAIN…
PWHL, Olympic champion Claire Thompson retires to pursue medical career
Canadian defenseman Claire Thompson is retiring from hockey at age 28 after returning to medical…
Comcast's NBCUniversal cuts streaming technology jobs
Oct 1 (Reuters) - Comcast's NBCUniversal is cutting jobs in its global streaming technology organization,…
